Literature DB >> 4574893

Radiosensitization of anoxic cells by metronidazole.

J L Foster, R L Willson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4574893     DOI： 10.1259/0007-1285-46-543-234

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  13 in total

Review 1.  Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes.

Authors:  Peter Wardman
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

Review 2.  The nitroimidazole family of drugs.

Authors: 
Journal:  Br J Vener Dis       Date:  1978-04

Review 3.  Free-radical mechanisms in tissue injury.

Authors:  T F Slater
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

Review 4.  Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs.

Authors:  D I Edwards
Journal:  Br J Vener Dis       Date:  1980-10

5.  Metronidazole (Flagyl), misonidazole (Ro 07-0582), iron, zinc and sulphur compounds in cancer therapy.

Authors:  D Bahnemann; H Basaga; J R Dunlop; A J Searle; R L Willson
Journal:  Br J Cancer Suppl       Date:  1978-06

Review 6.  Assessing the bioreductive effectiveness of the nitroimidazole RSU1069 and its prodrug RB6145: with particular reference to in vivo methods of evaluation.

Authors:  J C Bremner
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

7.  Comparative studies of hypoxic-cell radiosensitization using artificially hypoxic skin in vivo.

Authors:  J Denekamp; B D Michael; A I Minchinton; C E Smithen; F A Stewart; M R Stratford; N H Terry
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640

8.  Serum concentration measurements in man of the radiosensitizer Ro-07-0582: some preliminary results.

Authors:  J L Foster; I R Flockhart; S Dische; A Gray; I Lenox-Smith; C E Smithen
Journal:  Br J Cancer       Date:  1975-06       Impact factor: 7.640

9.  Cytotoxicity of metronidazole (Flagyl) and misonidazole (Ro-07-0582): enhancement by lactate.

Authors:  J S Mahood; R L Willson
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

10.  A possible combination of hypoxic cell sensitizer with an oxic protector: implications for radiotherapy.

Authors:  D Krishnan; D R Singh; U Madhvanath
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.